Residency · Rochester, MN
Sponsored by Mayo Clinic College of Medicine and Science
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Andrea Mariani
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 914 citations · Myra Wick
The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder.
The Journal of urology · 2024 · 162 citations · Brian Linder
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Andrea Mariani
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 587 citations · Jamie Bakkum-Gamez
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 289 citations · Myra Wick
Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update.
Gynecologic oncology · 2023 · 160 citations · Gretchen Glaser, Jamie Bakkum-Gamez, Sean Dowdy
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 346 citations · Jamie Bakkum-Gamez